发明名称 SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
摘要 The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.;
申请公布号 US2016130259(A1) 申请公布日期 2016.05.12
申请号 US201414898250 申请日期 2014.06.19
申请人 Merck Sharp & Dohme Corp. 发明人 Liu Hong;Dai Xing;Palani Anandan;He Shuwen;Nargund Ravi;Xiao Dong;Dang Qun;Peng Xuanjia;Li Peng
分类号 C07D405/14;C07D491/048;C07D498/04;C07D471/04;C07D471/14;A61K31/4985;A61K31/4439;A61K31/444;A61K31/501;A61K31/497;A61K31/506;C07D413/14;A61K45/06 主分类号 C07D405/14
代理机构 代理人
主权项 1. A compound having the formula: or a pharmaceutically acceptable salt thereof, wherein: X is Bis a) Ar; or b) —C(═O)NHCR5R6Ar; orX together with B is Ar is an aromatic ring system selected from: 5-6 membered monocyclic ring with 0, 1, or 2 N ring atoms, optionally substituted with halo or fluorophenyl; and(ii) 9-10 membered bicyclic rings with 0, 1, 2 or 3 heteroatom ring atoms selected from N and O, which is optionally substituted with 1 or 2 substituents independently selected from C1-C6 alkyl, F, cyano, and alkylalkoxy;A is fluorophenyl;D is absent or NR3SO2R4;Ra is C1-C6 alkyl or C1-C6 haloalkyl;R2 is C1-C6 alkyl;R3 is C1-C6 alkyl;R4 is C1-C6 alkyl;R5 is hydrogen, C1-C6 alkyl, or C1-C6 hydroxyalkyl;R6 is hydrogen; orR5 and R6 together with the carbon to which they are attached form cyclopropyl.
地址 Rahway NJ US